Search for: "Gene Grant" Results 461 - 480 of 998
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
28 Feb 2008, 8:57 am
Norris raises the sole issue of whether the trial court improperly granted summary disposition. [read post]
12 Feb 2007, 11:37 am
A time is marked not so much by ideas that are argued about as by ideas that are taken for granted. [read post]
11 Aug 2010, 8:54 am by Moseley Collins
The trial judge's power to grant a judgment notwithstanding the verdict is identical to his power to grant a directed verdict. [read post]
19 Oct 2010, 10:42 pm by Marie Louise
Honeywell (Patents Post-Grant) (IPBiz) (Patently-O) US: ‘At home’ testing for BRCA gene mutations (Patent Docs) US: New draft guidance for industry: INDs – determining whether human research studies can be conducted without an IND (FDA Law Blog) US: Patent extensions: some academic perspectives? [read post]
11 Mar 2010, 12:28 pm by Stephen Albainy-Jenei
Specifically, the ’698 patent, entitled “Lysine Decarboxylase Gene and Method of Producing L-Lysine,” discloses the identification of the lysine decarboxylase gene ldc and the creation of an E. coli strain with mutations in ldc that reduce or eliminate lysine decarboxlyase activity. [read post]
8 Apr 2016, 12:42 pm by Camilla Alexandra Hrdy
During the litigation, DOJ reversed course and adopted a position on subject matter eligibility that contradicted PTO’s longstanding policy of granting gene patents. [read post]
10 Jan 2023, 8:06 am by Rebecca Tushnet
Category (1) was unproblematic; she failed to sufficiently allege how (2) involved a “transfer of genes,” but was granted leave to amend. [read post]
8 Apr 2016, 9:14 am by Lawrence B. Ebert
Patent No. 5,753,441 evaluatedin that case recited a method of screening for alterationsof the BRCA1 gene that included the steps of“amplifying all or part of a BRCA1 gene from [a] sampleusing a set of primers to produce amplified nucleic acidsand sequencing the amplified nucleic acids” and “comparing”the sequence with wild-type BRCA1. [read post]
1 Jul 2011, 4:25 pm
Since the EPC applies only to the patent granting procedure, the impact should be limited to patent enforcement in national courts. [read post]
27 Jul 2013, 2:32 pm by Sai Vinod
Monsanto argued that that the application of single bacterial gene (i.e. [read post]
15 Aug 2011, 2:00 am by Stefanie Levine
A first step for granting a patent is determining whether or not a patent application claims patentable subject-matter. [read post]
15 Aug 2011, 2:00 am by Stefanie Levine
A first step for granting a patent is determining whether or not a patent application claims patentable subject-matter. [read post]
6 Dec 2006, 6:45 pm
As discussed above, the record contains sufficient circumstantial evidence to permit the jury to imply that physicians directly infringe.Science: The USPTO and lower courts are responsible for granting and enforcing patent rights that run contrary to U.S. [read post]
29 Aug 2011, 11:57 pm
The sequencing of the genes tests for mutations that increase the risk of a woman getting breast and ovarian cancer. [read post]
11 Jun 2011, 11:01 am by Oliver G. Randl
Therefore, plant varieties containing genes introduced into an ancestral plant by recombinant gene technology are excluded from patentability. [read post]
27 Oct 2008, 9:32 pm
Gene Fidell observes that following the passage of the Military Justice Act of 1983, "[i]t took nine years before the number" of military cert petitions "exceeded two hundred. [read post]
27 Oct 2010, 3:38 am by Kelly
Highlights this week included: CAFC: Patentability of isolated genes Association for Molecular Pathology v USPTO and Myriad Genetics – Myriad files brief (Patently-O) (Holman’s Biotech IP Blog) (Holman’s Biotech IP Blog) Glivec (Imatinib) – Brazil: Supreme Court of Justice denies extension of Glivec patent (IP tango) Plavix (Clopidogrel) – US: $442 million fine against Apotex for Plavix patent infringement (GenericsWeb) (Philip Brooks’ Patent Infringement… [read post]
7 Apr 2010, 4:30 am
– Myriad stock prices: Association of Molecular Pathology v USPTO (Innovationpartners) US: Federal judge in Myriad patent case says invalidation of gene patents does not violate TRIPS: Association of Molecular Pathology v USPTO (KEI) US: ACLU gene patent decision from an investor’s perspective: A black eye for the US patent system: Association of Molecular Pathology v USPTO (Holman's Biotech IP Blog) US: Association of Molecular Pathology v USPTO: What the parties… [read post]
25 Feb 2016, 2:39 pm
  The ostensible point of dog shows is to reward the best specimens of each breed so they will pass their genes to future generations, so it is neat when a judge’s good decision is affirmed. [read post]
28 Jun 2016, 5:55 am by Gritsforbreakfast
But defendants have no right to counsel to help write and file the writs in which they seek to convince the CCA to grant such a hearing. [read post]